Amid daily updates from the pharmaceuticals industry on the latest clinical trials, last week’s announcement by Hutchison China MediTech that it had enrolled patients for a study of colorectal cancer was hardly cause for excitement.
在製藥業每天都宣佈最新臨牀試驗的大背景下，和黃中國醫藥科技(Hutchison China MediTech)上週宣佈已徵募病患參加結直腸癌研究的訊息，算不上令人振奮。
您已閱讀4%（316字），剩餘96%（7184字）包含更多重要資訊，訂閱以繼續探索完整內容，並享受更多專屬服務。